Zobrazeno 1 - 10
of 11 406
pro vyhledávání: '"relapsed"'
Autor:
Cheng Zhang, Xiaoqi Wang, Hai Yi, Yi Wang, Zhiling Yan, Jian Zhou, Ting Yang, Aibin Liang, Zhen Wang, Yingying Ma, Qin Wen, Lei Gao, Li Gao, Peiyan Kong, Xu Tan, Erlie Jiang, Xi Zhang
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-4 (2024)
Abstract Chimeric Antigen Receptor T (CAR-T) cell therapy has significantly advanced in treating B-cell acute lymphoblastic leukemia (B-ALL) and has shown efficacy in managing relapsed B-ALL after allogeneic hematopoietic stem cell transplantation (a
Externí odkaz:
https://doaj.org/article/b6df4d5250e9414d96aecce10cbf0346
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background As we delve into the intricate world of venetoclax combination therapy in relapsed or refractory acute myeloid leukemia (AML), our exploration not only aims to contribute to the current body of knowledge but also strives to inform
Externí odkaz:
https://doaj.org/article/c45798f47326429a914cb9f7c8578e0b
Autor:
Stefan Knop, Monika Szarejko, Norbert Grząśko, Sara Bringhen, Karolin Trautmann‐Grill, Artur Jurczyszyn, Angelo Vacca, Cyrus Khandanpour, Barbara Gamberi, Ludek Pour, Katrine F. Iversen, Michael T. Stumpp, Cosima Suter, Keith M. Dawson, Christof Zitt, Philippe Legenne, Vaia Stavropoulou, Martin F. Fey, Nicolas Leupin, Hartmut Goldschmidt
Publikováno v:
eJHaem, Vol 5, Iss 5, Pp 940-950 (2024)
Abstract MP0250 is a designed ankyrin repeat protein that specifically inhibits both vascular endothelial growth factor A (VEGF‐A) and hepatocyte growth factor (HGF), aiming at potentiating cancer therapy by disrupting the tumour microenvironment.
Externí odkaz:
https://doaj.org/article/d9320941c5f7443ea0d680430869e3d7
Autor:
ChiIeng Tou, LinFeng Ma
Publikováno v:
Radiology Case Reports, Vol 19, Iss 10, Pp 4497-4503 (2024)
Primary mediastinal large B-cell lymphoma (PMBCL) is a specific subtype of diffuse large B-cell lymphoma (DLBCL), which occurs more frequently in young women. PMBCL is an uncommon kind of cancer. R-EPOCH is a common therapeutic regimen that is suitab
Externí odkaz:
https://doaj.org/article/8dfe0799e24e451b96a2b0edbb0e4c4a
Autor:
Ya. V. Krylova, E. V. Kondakova, A. N. Gavrilenko, A. M. Chekalov, L. V. Fedorova, L. V. Stelmakh, E. V. Babenko, T. S. Shchegoleva, A. A. Gusak, V. V. Baykov, N. B. Mikhailova, A. D. Kulagin
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 153-158 (2024)
Recent advances in the diagnosis and understanding of follicular lymphoma (FL) pathogenesis have had a significant impact on therapeutic tactics. The life expectancy of patients has increased significantly. Currently, the 5-year overall survival of F
Externí odkaz:
https://doaj.org/article/561967c1236a4dbea2b3ce4004bf3c32
Autor:
Hakan Şat Bozcuk, Mehmet Artaç
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Objectives Synthetic data may proxy clinical data. At the absence of direct clinical data, this study aimed to compare Irinotecan and Ifosfamide (II) with Topotecan in synthetic, recurrent small cell lung cancer (SCLC) patients within a simu
Externí odkaz:
https://doaj.org/article/5aebcfd329354805a27e4ca840ac697e
Autor:
Xiaoshan Liu, Xiaomin Peng, Shu Yang, Haijin Liu, Shouhua Zhang, Jinhu Wang, Yuhan Ma, Yu Wu, Zhixuan Wang, Wenjun Weng, Yang Li
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract In patients with relapsed or refractory neuroblastoma (NB), the limited efficacy of conventional chemotherapies necessitates the exploration of new treatment options. Previous studies have highlighted the anti-tumor properties of arsenic tri
Externí odkaz:
https://doaj.org/article/18be1eecca914fa7b94afc822e24791b
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Purpose The current study aims to investigate the significance of N6-methyladenosine (m6A) methylationrelated genes in the clinical prognosis of childhood relapsed B-cell acute lymphoblastic leukemia (B-ALLL) patient. Methods Transcriptome d
Externí odkaz:
https://doaj.org/article/126062dd837c4b2e863b9363f8678000
Autor:
S. K. Zyryanov, I. N. Dyakov
Publikováno v:
Фармакоэкономика, Vol 17, Iss 2, Pp 129-136 (2024)
Objective: to conduct a clinical and economic study of acalabrutinib for the treatment of adult patients with relapsed/refractory form of mantle cell lymphoma who previously received at least one line of therapy in the Russian Federation.Material and
Externí odkaz:
https://doaj.org/article/338b38071e0947d4a72c818883742e92
Autor:
Manlio Fazio, Chiara Maria Catena Sorbello, Vittorio Del Fabro, Alessandra Romano, Maria Teresa Cannizzaro, Nunziatina Laura Parrinello, Benedetta Esposito, Sara Frazzetto, Federica Elia, Francesco Di Raimondo, Concetta Conticello
Publikováno v:
Hematology Reports, Vol 16, Iss 3, Pp 541-551 (2024)
Neoplastic plasma cells (PCs) proliferation at anatomic sites dislocated from the bone marrow (BM) or their contiguous growth from osseous lesions that disrupt the cortical bone is termed extramedullary multiple myeloma (EMD). EMD still remains chall
Externí odkaz:
https://doaj.org/article/11046c4e4c2847b4bf27b2213c705ae2